stryker Blueprint Mixed Reality Instrument Kit, Catalog Number MRUEGLN; Total Shoulder Arthroplasty

FDA Device Recall #Z-1541-2025 — Class II — March 5, 2025

Recall Summary

Recall Number Z-1541-2025
Classification Class II — Moderate risk
Date Initiated March 5, 2025
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Tornier S.A.S.
Location Montbonnot-Saint-Martin, N/A
Product Type Devices
Quantity N/A

Product Description

stryker Blueprint Mixed Reality Instrument Kit, Catalog Number MRUEGLN; Total Shoulder Arthroplasty

Reason for Recall

Stryker identified an elevated complaint rate related to difficulties using the Blueprint Mixed Reality Guidance Instrumentation system is multifactorial, but in each instance prohibits the system from meeting its intended use. The most commonly reported complaints were related to impaired software functioning, impaired instrumentation functioning, and general difficulties using the product.

Distribution Pattern

US: TX, MN, AK, PA, MA, TN, ID, and France, Canada, and Ireland

Lot / Code Information

All lots manufactured through Oct 2024, Distributed 23-Aug-2023 through 31-Dec-2024, GTIN x

Other Recalls from Tornier S.A.S.

Recall # Classification Product Date
Z-1738-2025 Class II Blueprint Software, BPUE001. Intended for use ... Apr 10, 2025
Z-1537-2025 Class II stryker Blueprint Mixed Reality Instrument Chec... Mar 5, 2025
Z-1534-2025 Class II stryker Blueprint Mixed Reality BP MxR Glenoid ... Mar 5, 2025
Z-1535-2025 Class II stryker Blueprint Mixed Reality Glenoid Digitiz... Mar 5, 2025
Z-1542-2025 Class II stryker HoloBlueprint Application, Catalog Numb... Mar 5, 2025

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.